The FTC sued Cigna-owned Express Scripts, CVS-owned Caremark and UnitedHealth-owned Optum Rx in September, arguing that the drug middlemen prefer more expensive insulin products because they result in ...
Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up Express Scripts has completed the spinoff of its Rx Outreach ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The FTC’s complaint, filed in ...
The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up insulin prices through anticompetitive and unfair rebating practices, ...
The agreement includes sweeping changes for Cigna’s PBM, including no longer preferring expensive drugs over cheaper ...
Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to print (Opens in new window) Special to The ...
The Federal Trade Commission filed suit Friday against the nation’s three largest pharmacy benefit managers, including a division of Minnetonka-based UnitedHealth Group, alleging the companies have ...
Express Scripts, Caremark and OptumRx are suing the Federal Trade Commission for trying to "upend present day drug rebate contracts." The lawsuit was filed Tuesday, Nov. 19 in federal court in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results